Literature DB >> 21335427

Cell therapy for heart disease: to genetically modify or not, that is the question.

Muzammil Mushtaq, Behzad N Oskouei, Joshua M Hare.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21335427     DOI: 10.1161/CIRCRESAHA.111.240218

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  6 in total

Review 1.  Pharmacologic and genetic strategies to enhance cell therapy for cardiac regeneration.

Authors:  Rosemeire M Kanashiro-Takeuchi; Ivonne Hernandez Schulman; Joshua M Hare
Journal:  J Mol Cell Cardiol       Date:  2011-05-30       Impact factor: 5.000

Review 2.  Cell-based therapy for prevention and reversal of myocardial remodeling.

Authors:  Vasileios Karantalis; Wayne Balkan; Ivonne H Schulman; Konstantinos E Hatzistergos; Joshua M Hare
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-25       Impact factor: 4.733

3.  Controlled angiogenesis in the heart by cell-based expression of specific vascular endothelial growth factor levels.

Authors:  Ludovic F Melly; Anna Marsano; Aurelien Frobert; Stefano Boccardo; Uta Helmrich; Michael Heberer; Friedrich S Eckstein; Thierry P Carrel; Marie-Noëlle Giraud; Hendrik T Tevaearai; Andrea Banfi
Journal:  Hum Gene Ther Methods       Date:  2012-10       Impact factor: 2.396

Review 4.  Key developments in stem cell therapy in cardiology.

Authors:  Ivonne H Schulman; Joshua M Hare
Journal:  Regen Med       Date:  2012-11       Impact factor: 3.806

5.  Cloned, CD117 selected human amniotic fluid stem cells are capable of modulating the immune response.

Authors:  Emily C Moorefield; Elizabeth E McKee; Luis Solchaga; Guisseppe Orlando; James J Yoo; Steve Walker; Mark E Furth; Colin E Bishop
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

6.  Myogenic-induced mesenchymal stem cells are capable of modulating the immune response by regulatory T cells.

Authors:  Sunyoung Joo; Hyun Ju Lim; John D Jackson; Anthony Atala; James J Yoo
Journal:  J Tissue Eng       Date:  2014-02-18       Impact factor: 7.813

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.